(Q40130646)

17 September 2017

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study (English)

1 reference

17 September 2017

1 reference

1 reference

Michael Pinkawa

1

1 reference

17 September 2017

Richard Holy

2

1 reference

17 September 2017

Marc D Piroth

3

1 reference

17 September 2017

Karin Fischedick

4

1 reference

17 September 2017

Sandra Schaar

5

1 reference

17 September 2017

Dalma Székely-Orbán

6

1 reference

17 September 2017

Michael J Eble

7

1 reference

17 September 2017

8 April 2010

1 reference

17 September 2017

1 reference

17 September 2017

5

1 reference

17 September 2017

27

1 reference

Creative Commons Attribution 2.0 Generic

17 September 2017

start time

8 April 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Radiation dose-volume effects in radiation-induced rectal injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Image guided dose escalated prostate radiotherapy: still room to improve

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Consequential late effects in normal tissues

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Argon beam coagulation for treatment of symptomatic radiation-induced proctitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Surgery vs. radiotherapy in localized prostate cancer. Which is best?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Interpreting the significance of changes in health-related quality-of-life scores.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857853

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

20 August 2018

1 reference

12 December 2020

Erectile dysfunction after external beam radiotherapy for prostate cancer

1 reference

12 December 2020

Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage

1 reference

12 December 2020

Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer

1 reference

12 December 2020

Late GI and GU complications in the treatment of prostate cancer

1 reference

12 December 2020

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V

1 reference

12 December 2020

Rectal fistulas after prostate brachytherapy

1 reference

12 December 2020

Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-5-27

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference

17 September 2017

PubMed publication ID

20377874

1 reference